Clinical Trials Logo

Carcinoma of Anal Canal clinical trials

View clinical trials related to Carcinoma of Anal Canal.

Filter by:
  • None
  • Page 1

NCT ID: NCT01843452 Terminated - Clinical trials for Carcinoma of Anal Canal

Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

Start date: December 2012
Phase: Phase 2
Study type: Interventional

There is increasing evidence of a role of EGFR, treatment with EGFR-inhibitors in anal cancer and synergies of EGFR-inhibitors with radiotherapy. Addition of the human anti-EGFR antibody Panitumumab to chemoradiotherapy seems therefore solidly justified. This trial investigates concurrent panitumumab/capecitabine/mitomycin concurrent to IMRT-radiotherapy. Treatment components used in this study have been selected on scientific rationale. The trial regimen should be feasible with acceptable toxicity and outcome similar to historic series.